Pei Jin

Pei Jin has a strong background in biologics discovery and development, with over 20 years of work experience. Pei is currently working at Enosi Therapeutics as the Vice President of Discovery Research since January 2023. Prior to this, they served as a Biologics Development Consultant to the CSO at Enosi Therapeutics from August 2022 to January 2023.

Before joining Enosi Therapeutics, Pei Jin worked at Novartis Biologics for over 12 years, starting in July 2009 as the Lab Head for Antibody & Protein Design. During their tenure, Novartis Biologics achieved numerous FDA-approved clinical products.

From March 2004 to February 2009, Pei Jin served as the Sr. Director of Molecular Technology at Receptor BioLogix, where they led the pre-clinical development of bispecific biologics.

Prior to that, they worked as a Sr. Scientist at Incyte Corp from 1999 to 2004, and as a Scientist at Mitotix from 1998 to 1999.

Overall, Pei Jin's work experience showcases their expertise in biologics discovery, development, and pre-clinical research.

Pei Jin has a strong education background in the field of Cell Biology. Starting in 1986, Pei Jin attended Karolinska Institutet and received a Dr. Med Sci degree in Cell Biology in 1991. Following this, from 1992 to 1994, Pei Jin pursued post-doctoral studies at Harvard Medical School, focusing on the Regulation of mRNA processing. Continuing the research in the field, from 1994 to 1998, Pei Jin carried out further post-doctoral studies at the University of California, San Francisco, specifically researching mammalian cell cycle and checkpoint control.